/
/
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
This content is Free Access.
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
23,816 Views
•
11:15 min
•
September 20, 2016
DOI:
Summary
Automatically generated
This manuscript describes clinical protocols for two next-generation sequencing panels. One panel interrogates hematologic malignancies while the other panel targets genes commonly mutated in solid tumors. Molecular classification of driver mutations in human malignancies offers valuable prognostic and predictive information.
Read Article
Cite this Article
Fox, A. J., Hiemenz, M. C., Lieberman, D. B., Sukhadia, S., Li, B., Grubb, J., Candrea, P., Ganapathy, K., Zhao, J., Roth, D., Alley, E., Loren, A., Morrissette, J. J. D. Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors. J. Vis. Exp. (115), e52758, doi:10.3791/52758 (2016).
Copy